Literature DB >> 11152695

Expression pattern and gene characterization of asporin. a newly discovered member of the leucine-rich repeat protein family.

S P Henry1, M Takanosu, T C Boyd, P M Mayne, H Eberspaecher, W Zhou, B de Crombrugghe, M Hook, R Mayne.   

Abstract

We have discovered a new member of the class I small leucine-rich repeat proteoglycan (SLRP) family which is distinct from the other class I SLRPs since it possesses a unique stretch of aspartate residues at its N terminus. For this reason, we called the molecule asporin. The deduced amino acid sequence is about 50% identical (and 70% similar) to decorin and biglycan. However, asporin does not contain a serine/glycine dipeptide sequence required for the assembly of O-linked glycosaminoglycans and is probably not a proteoglycan. The tissue expression of asporin partially overlaps with the expression of decorin and biglycan. During mouse embryonic development, asporin mRNA expression was detected primarily in the skeleton and other specialized connective tissues; very little asporin message was detected in the major parenchymal organs. The mouse asporin gene structure is similar to that of biglycan and decorin with 8 exons. The asporin gene is localized to human chromosome 9q22-9q21.3 where asporin is part of a SLRP gene cluster that includes extracellular matrix protein 2, osteoadherin, and osteoglycin. Further analysis shows that, with the exception of biglycan, all known SLRP genes reside in three gene clusters.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11152695     DOI: 10.1074/jbc.M011290200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Replication of the association of the aspartic acid repeat polymorphism in the asporin gene with knee-osteoarthritis susceptibility in Han Chinese.

Authors:  Qing Jiang; Dongquan Shi; Long Yi; Shiro Ikegawa; Yong Wang; Takahiro Nakamura; Di Qiao; Cheng Liu; Jin Dai
Journal:  J Hum Genet       Date:  2006-09-21       Impact factor: 3.172

Review 2.  Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction.

Authors:  Liliana Schaefer; Renato V Iozzo
Journal:  J Biol Chem       Date:  2008-05-06       Impact factor: 5.157

Review 3.  The biology of small leucine-rich proteoglycans in bone pathophysiology.

Authors:  Dragana Nikitovic; John Aggelidakis; Marian F Young; Renato V Iozzo; Nikos K Karamanos; George N Tzanakakis
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

Review 4.  Proteoglycans in liver cancer.

Authors:  Kornélia Baghy; Péter Tátrai; Eszter Regős; Ilona Kovalszky
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 5.  Molecular therapy of the intervertebral disc.

Authors:  S Tim Yoon; Nilpesh M Patel
Journal:  Eur Spine J       Date:  2006-07-12       Impact factor: 3.134

Review 6.  Functions of lumican and fibromodulin: lessons from knockout mice.

Authors:  Shukti Chakravarti
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

7.  Binding characteristics of the osteoarthritis-associated protein asporin.

Authors:  Ikuyo Kou; Masahiro Nakajima; Shiro Ikegawa
Journal:  J Bone Miner Metab       Date:  2010-01-07       Impact factor: 2.626

8.  Molecular profiling of the developing mouse axial skeleton: a role for Tgfbr2 in the development of the intervertebral disc.

Authors:  Philip Sohn; Megan Cox; Dongquan Chen; Rosa Serra
Journal:  BMC Dev Biol       Date:  2010-03-09       Impact factor: 1.978

9.  Absence of association of asporin polymorphisms and osteoarthritis susceptibility in US Caucasians.

Authors:  U Atif; A Philip; J Aponte; E M Woldu; S Brady; V B Kraus; J M Jordan; M Doherty; A G Wilson; R W Moskowitz; M Hochberg; R Loeser; J B Renner; M Chiano
Journal:  Osteoarthritis Cartilage       Date:  2008-04-22       Impact factor: 6.576

10.  Asporin, a susceptibility gene in osteoarthritis, is expressed at higher levels in the more degenerate human intervertebral disc.

Authors:  Helen E Gruber; Jane A Ingram; Gretchen L Hoelscher; Natalia Zinchenko; Edward N Hanley; Yubo Sun
Journal:  Arthritis Res Ther       Date:  2009-03-27       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.